Makoto Emori

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells

Naotaka Hayasaka, Kohichi Takada, Hajime Nakamura et al. · Scientific Reports · 2019 · 155 citations · Full text

Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report

Kohichi Takada, Shintaro Sugita, Kazuyuki Murase et al. · Thoracic Cancer · 2019 · 108 citations · Full text

<scp>SYT</scp>‐<scp>SSX</scp> breakpoint peptide vaccines in patients with synovial sarcoma: <scp>A</scp> study from the <scp>J</scp>apanese <scp>M</scp>usculoskeletal <scp>O</scp>ncology <scp>G</scp>roup

Satoshi Kawaguchi, Tomohide Tsukahara, Kazunori Ida et al. · Cancer Science · 2012 · 93 citations · Full text

Immunodeficiencies, Immunology, Pathology +27

The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

Marilyn Heng, Abha A. Gupta, Peter Chung et al. · European Journal of Cancer · 2019 · 77 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +7

NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma

Shintaro Sugita, Yasuhito Arai, Tomoyuki Aoyama et al. · Human Pathology · 2017 · 73 citations

Malignant Disease, Pathology, Cic-rearranged Sarcoma +5